Nicholas Kian Mollanazar, M.D., M.B.A.

faculty photo
Assistant Professor of Clinical Dermatology
Department: Dermatology

Contact information
Department of Dermatology
Hospital of the University of Pennsylvania
3400 Civic Center Boulevard
Philadelphia, PA 19104
Education:
BS (Neuroscience and Behavioral Biology)
Emory University, Atlanta, GA, 2010.
MBA (Master of Business Administration)
Temple University Fox School of Medicine, Philadelphia, PA, 2015.
MD (Doctor of Medicine)
Temple Univeristy School of Medicine, 2015.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Elmariah S, Kim B, Berger T, Chisolm S, Kwatra SG, Mollanazar N, Yosipovitch G: Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus. J Am Acad Dermatol. 84(3): 747-760, March 2021 Notes: doi: 10.1016/j.jaad.2020.07.025. Epub 2020 Jul 15.

Sreekantaswamy SA, Mollanazar N, Butler DC: Gabapentinoids for Pruritus in Older Adults: A Narrative Review. Dermatol Ther (Heidelb) March 2021 Notes: doi: 10.1007/s13555-021-00513-z. Epub ahead of print.

Pousti, Bobak & Jin, Annie & Zhai, Lisa & Mollanazar, Nicholas: Dupilumab for the Treatment of Lichen Planus. Cutis; Cutaneous Medicine for the Practitioner 2021 Notes: 10.12788/cutis.0232.

Mollanazar NK, Savage KT, Pousti BT, Jariwala N, Del Guzzo C, Haun P, Vittorio C, Rook AH, Kim EJ.: Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumab. Cutis 106(3): 131-132, September 2020 Notes: doi: 10.12788/cutis.0066. PMID: 33104116.

Dany M, Fischer AS, Mollanazar NK, Rubin AI, Elenitsas R: CD30-positive atypical lymphocytes in perniosis: a potential diagnostic pitfall in a benign inflammatory dermatosis. J Cutan Pathol. 47(9): 781-784, September 2020 Notes: doi: 10.1111/cup.13697.

Ran, N. A., Samimi, S. S., Zhang, J., Chaiyachati, K. H., Mallozzi, C.P., Mollanazar, N. K.: Redeployment of dermatologists during COVID-19: Implementation of a large-scale, centralized results management infrastructure. Journal of the American Academy of Dermatology 83(3): 974-976, 2020.

Jin Annie, Pousti Bobak T, Savage Kevin T, Mollanazar Nicholas K, Lee Jason B, Hsu Sylvia: Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia. JAAD case reports 5(9): 815-817, Sep 2019.

Zhai Lisa L, Savage Kevin T, Qiu Connie C, Jin Annie, Valdes-Rodriguez Rodrigo, Mollanazar Nicholas K: Chronic Pruritus Responding to Dupilumab-A Case Series. Medicines (Basel, Switzerland) 6(3), Jun 2019.

Mollanazar N K, Qiu C C, Aldrich J L, Tedaldi E, Valdes-Rodriguez R, Savage K T, Hsu S: Use of dupilumab in patients who are HIV-positive: report of four cases. The British journal of dermatology Jun 2019 Notes: doi: 10.1111/bjd.18222. [Epub ahead of print]

Mollanazar Nicholas K: Restrictive FDA Requirements and the Development of Generic Topical Medications. JAMA dermatology 155(4): 503, Feb. 2019.

back to top
Last updated: 10/12/2021
The Trustees of the University of Pennsylvania